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The aim of this study was to compare the differential gene expression and stemness in the human gingiva and dental follicles (DFs)
according to their biological characteristics. Gingiva (𝑛 = 9) and DFs (𝑛 = 9) were collected from 18 children. Comparative gene
expression profiles were collected using cDNA microarray. The expression of development, chemotaxis, mesenchymal stem cells
(MSCs), and induced pluripotent stem cells (iPSs) related geneswas assessed by quantitative reverse transcription-polymerase chain
reaction (qRT-PCR). Histological analysis was performed using hematoxylin-eosin and immunohistochemical staining. Gingiva
had greater expression of genes related to keratinization, ectodermal development, and chemotaxis whereas DFs exhibited higher
expression levels of genes related to tooth and embryo development. qRT-PCR analysis showed that the expression levels of iPSc
factors including SOX2, KLF4, and C-MYC were 58.5±26.3, 12.4±3.5, and 12.2±1.9 times higher in gingiva andVCAM1 (CD146)
and ALCAM (CD166) were 33.5 ± 6.9 and 4.3 ± 0.8 times higher in DFs. Genes related to MSCs markers including CD13, CD34,
CD73,CD90, andCD105were expressed at higher levels in DFs.The results of qRT-PCR and IHC staining supported themicroarray
analysis results. Interestingly, this study demonstrated transcription factors of iPS cells were expressed at higher levels in the gingiva.
Given theminimal surgical discomfort and simple accessibility, gingiva is a good candidate stemcell source in regenerative dentistry.
1. Introduction
Tissue engineering using mesenchymal stem cells (MSCs)
is one of the most promising therapeutic strategies because
MSCs have a high proliferation potential and may be manip-
ulated to permit differentiation before transplantation [1, 2].
To date, different human dental stem cells have been isolated
from dental pulp stem cells (DPSCs) [3], stem cells from
exfoliated deciduous teeth (SHED) [4], periodontal ligament
(PDL) stem cells [5], stem cells from apical papilla (SCAP)
[6], and dental follicle precursor cells (DFPCs) [7]. Recently,
mounting evidence suggests that gingiva derived mesenchy-
mal stem cells were isolated and characterized as having
multilineage differentiation capacity and immunomodula-
tory properties [8]. The presence of stem cell populations in
dental follicles and the gingiva was revealed recently, and the
related gene expression patterns remain unclear.
The dental follicle (DF) tissue is a connective fibrous tis-
sue sac surrounding the enamel organ and the dental papilla
of the developing tooth germ [9]. The DF cells have been
proposed to have the capacity to differentiate into periodon-
tium consisting of cementum, alveolar bone, and PDL [10, 11].
Despite an ectomesenchymal origin similar to that of theDFs,
the gingiva appears to exhibit distinct functional activities
during themaintenance of tissue integrity and during inflam-
matory responses [12]. It possesses a unique scarless healing
process after wounding instead of the scar formation that is
frequently observed in damaged extraoral tissues. So gingival
tissue is postulated to have distinctive characteristics that
Hindawi Publishing Corporation
Stem Cells International
Volume 2016, Article ID 8596520, 11 pages
http://dx.doi.org/10.1155/2016/8596520
2 Stem Cells International
accelerate wound closure, suggesting unique stemness with
the ability to induce directed differentiation and regeneration.
Although some efforts were made to identify the genes
that are differentially expressed in the periodontium [12–14],
the genetic differences between the gingiva and DFs remain
unknown. Given the anatomical and functional differences
between the two tissues, it is reasonable to assume that
there are also differences in the gene expression patterns.
Thus, genetic investigation related to epithelial-mesenchyme
interaction between gingiva and dental follicle can provide
critical importance in regulating cell population and signal-
ing system in the regeneration of periodontium. The aim of
this study is to compare the gene expression patterns of the
gingiva and DFs to enhance our understanding of the dis-
tinct regenerative ability in gingiva and tissue differentiation
capacity in DFs.
2. Materials and Methods
The Institutional Review Board of the Yonsei University Den-
tal Hospital approved the experimental protocol (approval
number 2-2015-0005). All the subjects or their guardians
have providedwritten informed consent.We used procedures
similar to that recently applied by Song et al. [15] and Lee et
al. [14].
2.1. Tissue Sampling and RNA Isolation. Gingival tissues were
collected from children (𝑛 = 9) (5 males and 4 females, aged
7–12 years) with a healthy gingiva who underwent surgical
gingival resection for the extraction of a supernumerary
tooth, for odontoma, or for orthodontic reasons. The DF
tissues were obtained from children (𝑛 = 9) (6 males and
3 females, aged 6–8 years), and they were separated from
the coronal portion of the tooth during the extraction of
supernumerary teeth. In DF, a piece of gingival tissue around
the extraction socket was carefully curetted. These samples
were immediately frozen and stored in liquid nitrogen. We
used fresh tissue instead of cultured cells because, at the
tissue level, gene expression reflects simultaneous profiles
of many genes and can provide additional insights into the
physiological processes or tissue-specific functions that are
mediated by the coordinated action of sets of genes. Gingiva
and DFs were immediately submerged in RLT buffer, which
is a component of the RNeasy Fibrous Mini kit (Qiagen,
CA, USA). Prior to the RNA extraction, the tissues in
RLT buffer were homogenized using a Bullet Blender Bead
(Next Advanced, Inc., NY, USA). Total RNA was extracted
from gingiva and DFs using the RNeasy Fibrous Mini kit
(Qiagen, USA) according to the manufacturer’s instructions.
The extracted RNA was eluted in 25 𝜇L of sterile water. RNA
concentrations were measured from absorbance values at a
wavelength of 260 nmusing a spectrophotometer (NanoDrop
ND-2000, Thermo Scientific, IL, USA). The RNA samples
used in this study had 260/280 ratios of at least 1.8.
2.2. cDNA Microarray Construction and Data Analysis.
Global gene expression analyses were performed using
Affymetrix Gene Chip Human Gene 1.0 ST oligonucleotide
arrays (Affymetrix Inc., CA, USA). The average amount
of RNA isolated from the gingiva and DFs was 1𝜇g. As
recommended by the manufacturer’s protocol, 300 ng of
total RNA from each sample was converted to double-
stranded cDNA. The cDNA was regenerated via random-
primed reverse transcription using a dNTP mix containing
dUTP.The fragmented, end-labeled cDNAwas hybridized to
theGeneChipHumanGene 1.0 ST array for 16 hours at 45∘C
and 60 rpm with a terminal transferase reaction incorporat-
ing a biotinylated dideoxynucleotide. After hybridization, the
chips were stained and washed in a Genechip Fluidics Station
450 (Affymetrix) and scanned using a Genechip Array
scanner 3000 G7 (Affymetrix). To determine whether genes
were differentially expressed between the separated tissue
groups, a one-way ANOVA was performed on the Robust
Multi-Average (RMA) expression values. A multiple testing
correction was applied to the 𝑝 values of the 𝐹-statistics
to adjust the false discovery rate. Genes with adjusted 𝐹-
statistic𝑝 values<0.05were extracted. Genes that were highly
expressed in the gingiva or DFs and that exhibited differences
greater than 4-fold between the signal value of the control
and the test groupwere selected for further study.These genes
were then classified based on the information related to gene
function that is available in Gene Ontology from the KEGG
Pathway database (http://david.abcc.ncifcrf.gov/home.jsp).
This microarray data set was approved by the Gene Expres-
sion Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/);
the GEO accession numbers of the data set are GSE58480
(gingiva) and GSE51342 (dental follicle).
2.3. Quantitative RT-PCR. The single-stranded cDNA re-
quired for the polymerase chain reaction (PCR) analysis was
produced using 500 ng of extracted total RNA as a tem-
plate for reverse transcription (RT) (Superscript III Reverse
Transcriptase and random primer, Invitrogen, UK). The RT
reaction was incubated at 65∘C for 5 minutes, then 25∘C
(5min), 50∘C (1 hr), and 70∘C (15min) to inactivate the
activity of the reverse transcriptase. The synthesized cDNA
was diluted 1 : 10 in distilled water and used as a template
for quantitative RT-PCR using the ABI7300 RT-PCR system
(Applied Biosystems, Warrington, UK). The samples were
prepared in triplicate with a volume of 25𝜇L containing 1x
Universal TaqMan Master Mix (4369016, Applied Biosys-
tems), the PCR primers at 0.9 𝜇M, and the diluted cDNA.
The amplification conditions were 50∘C for 2 minutes and
95∘C for 10 minutes, followed by 40 cycles of 95∘C for 15
seconds and 60∘C for 1 minute. The following TaqMan gene
expression assay primers (Applied Biosystems) were used:
KRT6A, CXCL10, CSTA, AMBN, ADAM12, CXCL12, cMYC,
KLF4, SOX2, CD106 (VCAM1), CD166 (ALCAM), and 18S
rRNA.We selected known genes that are representative of the
two tissues and little-known genes that are involved in their
physiological functions.
ABI 7300 SDS 1.3.1 software (Applied Biosystems)
recorded the fluorescence intensity of the reporter and
quencher dyes, and results are plotted versus time, repre-
sented by the cycle number. The amplification plots were
examined during the early log phase of product accumulation
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Table 1: Specific primer used for quantitative RT-PCR analysis.
Gene symbol Functions Assay ID Product size (bp)
KRT6A Ectoderm development, positive regulation of cellproliferation, cell differentiation Hs01699178 g1 83
CXCL10 Positive regulation of leukocyte, chemotaxis Hs01124251 g1 135
CSTA Keratinocyte differentiation, negative regulation ofpeptidase activity Hs00193257 m1 114
AMBN Cell proliferation, bone mineralization, odontogenesisof dentin-containing tooth Hs00212970 m1 61
ADAM12 Cell-cell and cell-matrix interactions, includingfertilization, muscle development, neurogenesis Hs01106101 m1 54
CXCL12 Immune response, positive regulation of monocytechemotaxis Hs03676656 mH 88
C-MYC Regulation of transcription, DNA-dependent Hs00153408 m1 107
KLF4 Mesodermal cell fate determination, negative regulationof cell proliferation, regulation of transcription Hs00358836 m1 110
SOX2 Negative regulation of transcription from RNApolymerase II promoter, osteoblast differentiation Hs01053049 s1 91
CD106 Response to hypoxia, acute inflammatory response,chronic inflammatory response Hs01003372 m1 62
CD166 Cell adhesion, signal transduction, motor axonguidance Hs00977641 m1 103
18S rRNA Hs03003631 g1 69
above background (the threshold cycle number, Ct) to obtain
a precise quantification of initial target. The Ct values (the
threshold cycle (Ct) number) were subsequently used to
determine ΔCt values (ΔCt = Ct of the gene minus Ct of the
18S rRNA control). Relative expressions were expressed as
the relative change by applying the equation 2−ΔΔCt (ΔΔCt;
differences in ΔCt values). All these quantitative RT-PCR
procedures were done obtaining triplicated data. The results
were analyzed using SPSS 20 software (SPSS Inc., IL, USA).
Statistical differences were calculated by Mann–Whitney 𝑈
tests, and 𝑝 < 0.05 was considered statistically significant.
The specific primer assay ID and product sizes for each gene
are listed in Table 1.
2.4. Immunohistochemical Staining. For immunohistochem-
ical staining, gingival tissue and DF tissue were fixed in
10% buffered formalin for 1 day, embedded in paraffin,
and then sectioned at a thickness of 3𝜇m. The specimens
were subjected to IHC staining with antibodies specific for
CXCL10 (rabbit polyclonal, diluted 1 : 50; Ab9807, Abcam,
Cambridge, UK), CSTA (rabbit polyclonal, diluted 1 : 2,000;
Ab61223, Abcam), AMBN (rabbit polyclonal, diluted 1 : 200;
Ab116347, Abcam), and CXCL12 (rabbit polyclonal, diluted
1 : 50; Ab9797, Abcam). Endogenous peroxidase activity was
quenched via addition of 3% hydrogen peroxide.The sections
were incubated in 5%bovine serumalbumin to block nonspe-
cific binding.Theprimary antibodies were diluted to facilitate
optimal staining, and the sections were incubated overnight.
After incubation, EnVision+ System HRP-Labeled Polymer
anti-rabbit (K4003, Dako North America, Inc., CA, USA)
was applied for 20min. Color development was performed
using labeled streptavidin biotin kits (Dako) according to the
manufacturer’s instructions.
3. Results
3.1. Gene Expression Profiles of the Gingiva and Dental Folli-
cles. 1,182 out of 33,297 (3.6%) genes exhibited an absolute
expression change of at least 4-fold. The expression levels
of 555 genes were 4-fold higher in the gingiva than in DFs,
while the expression levels of 627 genes were at least 4-
fold higher in DFs than in the gingiva. The overall data
distribution and frequency were confirmed by density and
box plots of the ratio of the standardized log intensity to the
average intensity.Ultimately, 829 geneswere analyzed further,
with the exception of several genes with unknown biological
functions. The data were further filtered, and the genes are
listed in Tables 2 and 3 according to their relative biological
functions. In the gingiva, the expression levels of 387 genes
were upregulated by 4-fold or more in comparison to DFs,
while the expression levels of 442 genes were upregulated by
4-fold in DFs in comparison to the gingiva.
3.2. Gene Ontology Analysis. To identify the biological func-
tions and features of the selected genes, the expression data
sets were organized into Gene Ontology Consortium (GO)
groups using the DAVID web-based tool. These genes were
then classified based on information regarding gene function
in gene ontology from the KEGG Pathway database. Figure 1
shows GO classes for the two data sets analyzed (𝐹-statistic
𝑝 < 0.05).
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Table 2: Representative genes differentially expressed with higher expression levels in the gingiva than in dental follicles (absolute fold
change > 4.0).
Functional category Gene symbol Biological process Accession number Absolute fold change Standard deviation
Metabolism and
catabolism
LIPK Lipid catabolic process NM 001080518 90.99 11.87
FMO2 Organic acid metabolic process NM 001460 34.26 7.05
ARG1 Arginine catabolic process NM 000045 18.91 5.06
LIPN Lipid catabolic process NM 001080518 13.27 4.19
Protein modification
and maintenance
KLK7 Proteolysis NM 139277 30.47 6.52
KLK10 Proteolysis NM 002776 28.97 6.34
KLK6 Protein autoprocessing NM 002774 25.58 6.10
TGM1 Protein modification process NM 000359 22.21 5.48
OCLN Protein complex assembly NM 002538 12.48 4.48
Structural process
SPRR2A Keratinization NM 005988 207.84 18.61
KRT1 Keratinization NM 006121 146.08 15.41
CNFN Keratinization NM 032488 74.92 10.64
CSTA Keratinocyte differentiation NM 005213 69.63 10.22
KRT4 Cytoskeleton organization NM 002272 39.48 7.50
KRT3 Cytoskeleton organization NM 057088 36.71 7.23
FLG Keratinocyte differentiation NM 002016 24.31 5.75
DSP Keratinocyte differentiation NM 004415 17.15 5.22
Transport activity
CLCA4 Ion transport NM 012128 48.96 8.48
AQP3 Water transport NM 004925 27.74 6.41
SLC5A1 Transmembrane transport NM 000343 19.52 5.09
GLTP Glycolipid transport NM 016433 7.56 3.04
Developmental
process
KRT10 Epidermis development NM 000421 152.93 15.74
SCEL Epidermis development NM 144777 134.38 14.68
KRT6B Ectoderm development NM 005555 90.30 12.11
KRT6A Ectoderm development NM 005554 57.61 9.64
SPINK5 Epidermal cell differentiation NM 001127698 55.60 9.34
EHF Epithelial cell differentiation NM 012153 14.27 5.50
SOX2 Embryonic development NM 003106 8.67 3.34
TUFT1 Odontogenesis NM 020127 7.87 3.19
Physiologic process
RHCG Regulation of pH NM 016321 51.23 8.68
ABCA12 Cellular homeostasis NM 173076 39.33 7.55
EREG Angiogenesis NM 001432 13.04 4.29
NMU Gastric acid secretion NM 006681 12.72 4.05
SCD Oxidation reduction NM 005063 4.35 2.25
Nucleic acid synthesis
and modification
MACC1 Regulation of cell division NM 182762 20.30 5.38
ESRP1 mRNA processing NM 017697 17.02 5.85
HIST1H1B Nucleosome assembly NM 005322 6.85 2.91
Signal transduction
and regulation
IL1F9 Cell-cell signaling NM 019618 26.31 6.03
ARAP2 Signal transduction NM 015230 9.88 3.89
DAPP1 Signal transduction NM 014395 8.90 3.32
Apoptosis
MAL Induction of apoptosis NM 002371 49.41 8.48
ALOX12 Antiapoptosis NM 000697 31.70 6.69
FAM3B Apoptosis NM 058186 27.28 6.16
BNIPL Apoptosis NM 001159642 18.88 5.01
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Table 2: Continued.
Functional category Gene symbol Biological process Accession number Absolute fold change Standard deviation
Cell adhesion
CLDN17 Cell-cell adhesion NM 012131 91.67 11.90
CRNN Cell-cell adhesion NM 016190 71.09 10.39
DSC3 Homophilic cell adhesion NM 024423 27.40 6.38
CDSN Cell adhesion NM 001264 26.60 5.80
DSG3 Cell adhesion NM 001944 23.82 7.07
Cell cycle and
transcriptional
regulation
GRHL1 Regulation of transcription NM 198182 31.32 6.62
IRF6 Cell cycle arrest NM 006147 13.05 4.87
CASZ1 Regulation of transcription NM 001079843 4.29 2.27
E2F8 Regulation of transcription NM 024680 4.20 2.21
Immune and
inflammatory process
SERPINB4 Immune response NM 002974 73.33 10.65
IL1F6 Inflammatory response NM 014440 43.13 7.87
IL1RN Inflammatory response NM 173842 26.09 6.48
IL1A Inflammatory response NM 000575 23.93 5.74
CD1A Immune response NM 001763 4.16 2.19
Cytokine and
chemokine activity
CXCL17 Chemotaxis NM 198477 11.34 3.83
CCL21 Chemotaxis NM 002989 6.25 2.78
ANLN Cytokinesis NM 018685 5.84 2.63
CXCL10 Chemotaxis NM 001565 4.29 2.37
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Figure 1: Main categories of genes expressed in the gingiva and dental follicles according to biological process. 𝑥-axis: the number of involved
genes.
A total of 66 genes encoding metabolic and catabolic
process were expressed more abundantly in the gingiva than
in the DFs. Fifty-five genes related to structural processes
such as keratinization and cytoskeleton organization were
expressed at higher levels in the gingiva. On the other
hand, 92 developmental process-related genes were highly
expressed in DFs as a result of biological processes includ-
ing odontogenesis, ossification, and bone mineralization.
Cell cycle-associated genes and signal transduction- and
regulation-related genes were expressed at higher levels in
DFs. These results are consistent with the occurrence of
higher proliferation rates in DFs.
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Table 3: Representative genes differentially expressed with higher expression levels in dental follicles than in the gingiva (absolute fold change
> 4.0).
Functional category Gene symbol Biological process Accession number Absolute fold change Standard deviation
Metabolism and
catabolism
ALDH1L2 Carbon metabolic process NM 001034173 19.63 5.13
MOXD1 Histidine catabolic process NM 015529 17.92 4.91
ELOVL2 Fatty acid metabolic process NM 017770 12.62 4.07
FBXL7 Protein catabolic process NM 012304 8.58 3.27
Protein modification
and maintenance
ADAM12 Metalloendopeptidase activity NM 003474 37.09 7.25
MMP16 Metalloendopeptidase activity NM 005941 24.32 5.82
MMP2 Metalloendopeptidase activity NM 004530 19.64 5.17
MMP8 Metalloendopeptidase activity NM 002424 11.86 3.89
MMP13 Metalloendopeptidase activity NM 002427 7.60 3.16
ADAM22 Proteolysis NM 021723 5.97 2.75
Structural process
COL11A1 Extracellular matrix organization NM 001854 29.15 6.38
MAP1B Microtubule bundle formation NM 005909 10.30 3.61
FBN2 Anatomical structure morphogenesis NM 001999 9.02 3.40
LUM Collagen fibril organization NM 002345 8.68 3.32
Transport activity
KCNT2 Ion transport NM 198503 11.30 3.80
ABCC9 Potassium ion transport NM 005691 11.18 3.77
RHOBTB3 Retrograde transport NM 014899 10.62 3.72
SLC4A4 Sodium ion transport NM 001098484 10.12 3.68
HEPH Copper ion transport NM 138737 8.34 3.28
Developmental
process
AMBN Odontogenesis NM 016519 117.54 16.99
CDH11 Ossification NM 001797 38.12 7.40
ALPL Biomineral tissue development NM 000478 33.21 6.83
ASPN Bone mineralization NM 017680 33.05 6.85
FGF7 Embryonic development NM 002009 29.53 6.44
COL1A2 Skeletal system development NM 000089 14.50 4.41
RUNX2 Ossification NM 001024630 13.85 4.23
PDGFRB Embryonic development NM 002609 11.85 3.93
WNT2 Mesenchymal cell proliferation NM 003391 10.28 3.73
BMP5 Ossification NM 021073 7.13 3.28
LEF1 Wnt receptor signaling pathway NM 016269 5.83 2.66
PAX3 Organ morphogenesis NM 181457 4.70 2.38
MSX1 Organ morphogenesis NM 002448 4.23 2.24
Physiologic process
VAT1L Oxidation reduction NM 020927 12.30 3.98
TFPI Blood coagulation NM 006287 9.49 3.49
TPM1 Muscle contraction NM 000366 8.78 3.30
SOBP Sensory perception NM 018013 8.27 3.21
Nucleic acid synthesis
and modification
EYA4 DNA repair NM 004100 24.90 5.86
NAP1L3 Nucleosome assembly NM 004538 16.47 4.68
SNRPN RNA splicing BC043194 5.05 1.58
Signal transduction
and regulation
PDE7B Signal transduction NM 018945 22.99 5.59
CHN1 Signal transduction NM 018945 22.98 5.60
LIFR Cytokine-mediated signaling pathway NM 002310 8.78 3.31
FSTL1 BMP signaling pathway NM 007085 8.75 3.31
Apoptosis
SEMA3A Apoptosis NM 006080 51.87 8.72
PEG10 Apoptosis NM 015068 21.89 5.43
SULF1 Apoptosis NM 001128205 11.18 3.77
NELL1 Induction of apoptosis NM 006157 8.67 3.27
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Table 3: Continued.
Functional category Gene symbol Biological process Accession number Absolute fold change Standard deviation
Cell adhesion
OMD Cell adhesion NM 005014 40.83 7.69
VCAN Cell adhesion NM 004385 35.76 7.25
SPON1 Cell adhesion NM 006108 32.63 6.78
Cell cycle and
transcriptional
regulation
MYEF2 Transcription NM 016132 6.71 2.88
SYCP2 Cell cycle NM 014258 5.41 2.53
APBB2 Cell cycle arrest NM 004307 5.25 2.49
Immune and
inflammatory process
TPST1 Inflammatory response NM 003596 9.00 3.34
PXDN Immune response NM 012293 8.89 3.40
IFI44L Immune response NM 006820 6.01 2.79
PECAM1 Phagocytosis NM 000442 4.26 2.25
COLEC12 Phagocytosis, recognition NM 130386 4.23 2.22
Cytokine and
chemokine activity
CXCL12 Chemotaxis NM 000609 11.04 3.79
SLIT3 Chemotaxis NM 003062 8.94 3.34
CMTM3 Chemotaxis NM 144601 5.24 2.52
STX2 Cytokinesis NM 194356 4.39 2.27
CCR1 Chemotaxis NM 001295 4.31 2.36
3.3. Confirmation of Gene Differential Expression Using Quan-
titative RT-PCR. Quantitative RT-PCR analysis verified the
cDNA microarray results. Six genes for which the difference
in expression levels between the gingiva and DFs was at least
4-fold were selected. Mann–Whitney “𝑈” test was performed
to correlate the relative change with differential expression as
detected by PCR.The expression levels of KRT6A, CSTA, and
CXCL10were 13406.7± 14962.8, 1524.4± 714.8, and 4.7± 2.0
times higher in gingiva, and AMBN, ADAM12, and CXCL12
were 20585.4 ± 24267.0, 192.5 ± 66.5, and 66.0 ± 6.5 times
higher in DFs (Figure 2). These results were consistent with
the microarray results.
3.4. Verification of Array Results by Immunohistochemical
Staining. The following four proteins were the targets of the
IHC study: CXCL10, CSTA, AMBN, and CXCL12 (Figure 3).
CXCL10 was broadly stained in the epithelial area of the
gingiva. CSTA was strongly stained in all of the layers of the
gingiva. AMBN was not stained in the gingiva but stained
around the outer area of the DFs. CXCL12 was stained in a
single cellular layer and in the collagenous connective tissue
of DFs. The results were consistent with those of the cDNA
microarray analysis at the protein level.
3.5. Stemness Characterization by Surface Protein Markers.
Based on previous studies, dental stem cells were charac-
terized using surface protein markers [16, 17]. The com-
parative expression results for stem cell marker genes are
listed in Figure 4(a). Our results indicated that DF tissue
derived MSCs are a cell population that is more positive for
mesenchymal MSC markers (including CD13, CD34, CD73,
CD90, and CD105) according to the International Society
for Cell Therapy [18]. The comparative expression of four
induced pluripotent stem cells (iPSCs) marker genes (i.e.,
OCT-3, 4, SOX2, cMYC, and KLF4) were expressed at higher
levels in the gingiva. As a result of qRT-PCR, SOX2, KLF4,
KRT6A CSTA CXCL10 AMBN ADAM12 CXCL12
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Figure 2: The relative difference in mRNA expression of six dif-
ferentially expressed genes between the gingiva and dental follicles
using quantitative RT-PCR. The data are presented as the mean +
standard deviation and expressed as the relative change by applying
the equation 2−ΔΔCt. 𝑦-axis: a log scale measure. ∗∗𝑝 < 0.05.
and cMYC appeared 58.5, 12.43, and 12.23 times higher from
the gingiva and VCAM1 (CD106) and ALCAM (CD166) were
33.54 and 4.27 times higher in DFs (Figure 4(b)). However,
OCT-3, 4 did not show a clear difference in comparison to
the other markers (0.46-fold difference).
4. Discussion
In this study, a cDNA microarray comparison analysis was
performed to focus on differences in the gene expression
profiles of gingiva and DFs in children. The majority of
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Figure 3: Verification of microarray results by immunohistochemical (IHC) staining. Hematoxylin-eosin staining in the gingiva (a, f) and
dental follicles (DFs) (k, p) (asterisk: outer border neighboring alveolar bone). IHC staining for CXCL10 in the gingiva (b, g) and DFs (l,
q). IHC staining for CSTA in the gingiva (c, h) and DFs (m, r). The expression of CXCL10 and CSTA was stained markedly in the gingival
epithelium. The IHC staining for AMBN in the gingiva (d, i) and DFs (n, s). AMBN was stained around the outer layer of the DFs. The IHC
staining for CXCL12 in the gingiva (e, j) and dental follicles (o, t). CXCL12 was stained in both a cellular layer and the collagenous connective
tissue of DFs (scale bars: 200𝜇m).
genes (32,115 out of 33,297, 96.5%) showed similar expression
level between the gingiva and DFs when using a 4-fold
absolute change cutoff value.Most of those genes encoded cell
adhesion proteins, proteins involved in structural processes,
or proteins related to signal transduction and regulation.
This finding suggests that the gingiva and DFs differentiate
into different tissue later although they originate from an
ectomesenchymal cell. This is likely due to the regulation
of comparable intracellular signaling pathways. In contrast,
approximately 4% of genes were differentially expressed
above the selected threshold. While accounting for only a
small portion of the whole gene array, these genes might
contribute to the distinct biological functions and distin-
guish each other phenotypically and morphologically. To
investigate this assumption, comparative gene expressionwas
analyzed with respect to the biological functions of the genes.
In the gingiva, KRT1, CSTA, and FLG were expressed
at significantly higher levels. The gingival epithelium is
a stratified squamous keratinizing tissue, and these genes
are related to keratinization or keratinocyte differentiation.
KRT1 marks the cornification pathway of differentiation
and is expressed in keratinized areas [19]. CSTA is one
of the precursor proteins of the cornified cell envelope in
keratinocytes and plays a role in epidermal development
and maintenance [20]. FLG is essential for the regulation of
epidermal homeostasis and interacts with keratin interme-
diate filaments [21]. Epidermis and ectoderm development-
related genes were strongly upregulated in the gingiva versus
DFs. KRT6B and KRT6A were markedly upregulated in
the gingiva, with 90.30- and 57.61-fold differential expres-
sion, respectively. These proteins are rapidly induced in
wound-proximal epidermal keratinocytes after skin injury
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Figure 4: The relative gene expression of dental-derived stem cell
and induced pluripotent stem cell markers using cDNA microarray
(a). The relative fold difference in the expression of five stem
cell marker genes between the gingiva and dental follicles using
quantitative RT-PCR (b). The data are presented as the mean +
standard deviation (a, b) and expressed as the relative change by
applying the equation 2−ΔΔCt (b). ∗∗𝑝 < 0.05.
and regulate the migratory potential of skin keratinocytes
duringwound repair [22]. SCELmay function in the assembly
or regulation of proteins in the keratinized envelope [23].
The upregulation of these genes may indicate the existence
of a fast turnover rate in the gingiva and may facilitate
fibroblast proliferation, which is an important event for tissue
repair.
The oral mucosa is affected by exposure to various extrin-
sic factors such as chemicals and microorganisms. Genes
related to apoptosis and chemotaxis such asCXCL10,CXCL17,
ANLN, and CCL21 were strongly expressed in the gingiva.
CXCL10 is secreted by the keratinocytes and is a marker
of the host immune response [24]. This chemokine plays
an important role in the infiltration of Th1 cells and affects
the gingiva by exacerbating periodontal disease [25]. The
overexpression of these chemokines might be associated with
the generation and delivery of immune and inflammatory
responses in the gingiva.
On the other hand, genes related to tooth and embryo
development exhibited significantly higher expression in
DFs. These results are consistent with those of a previous DF
gene expression study that compared DFs to the PDL [14].
The increased expression of AMBN indicates that DFs play
an important role in enamel matrix formation and mineral-
ization [26]. In this study,WNT2 and LEF1 were upregulated
in DFs suggesting that DFs are involved in the complex
interplay of signaling factors that regulate tooth initiation
and morphogenesis [27, 28]. Runx2 is a key regulator of
osteoblast marker genes and promotes the differentiation
of mesenchymal stem cells into osteoblasts. The literature
indicates thatRunx2 functions in the dentalmesenchyme and
mediates transduction signals from the dental epithelium to
themesenchyme during tooth development [29]. It also influ-
ences the molecular events that regulate tooth eruption—the
most important physiologic role is likely being at the eruptive
site [30]. Given the adaptive role of DFs, the presence of these
genes suggests a central role of DFs in tooth formation.
Genes encoding protein modification- and signal trans-
duction-related proteins tend to be expressed at higher levels
in DFs than in the gingiva. The metalloprotease ADAM
12 has been implicated in biological processes including
fertilization and neurogenesis in DFs [11]. MMP-13 may be
a major collagenolytic enzyme that degrades the extracellular
matrix during tooth eruption. The upexpression of MMP-13
means DFs have important functions for the coordination
of tooth eruption [31]. CXCL12 is a chemotactic factor
for mesenchymal stem cells and mediates the suppressive
effect of those cells on osteoclastogenesis. This factor can be
expressed in DFs during tooth development including the
epithelium surrounding the developing tooth bud [32].
To verify cDNA microarray results, six genes of different
functions were selected for quantitative RT-PCR analyses.
The expression levels of KRT6A, CSTA, and CXCL10 were
upregulated in the gingiva; AMBN, ADAM12, and CXCL12
were upregulated in DFs. These results were consistent with
the microarray results. To better understand the roles of the
differentially expressed genes, IHC analysis was performed to
identify their functions at tissue level.CXCL10 andCSTAwere
strongly stained in all of the layers of the gingival tissue but
were not stained in DFs. The genes that are highly expressed
in the gingiva are stained in the epithelium because the
prominent difference in structure between the gingiva and
DFs is in the keratinized epithelium. AMBN and CXCL12
were broadly stained in the outer area of DFs especially in
the reduced enamel epithelium.
Several cell populations with stem cells properties have
been isolated from different parts of dental tissue. Their
participation in tissue repair and maintenance has been
proposed [1]. Although it is difficult to characterize dental
stem cells using surface protein markers, our results indicate
the relative overexpression of important markers including
CD13, CD34, CD73, and CD105 in DFs. These are ubiqui-
tously expressed by all dental stem or precursor cells [6,
16]. With the exception of CD90, CD13, and CD34 which
were frequently cited as dental-derived stem cell markers in
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previous studies, we selected CD106 (VCAM1) and CD166
(ALCAM), which are expressed more strongly in dental
follicles. Other dental-derived stem marker genes including
CD29, CD90, and CD73 were expressed at higher levels
indicating self-renewing and differentiation capacities in DFs
[33].
Interestingly, the gingiva expressed high levels of iPS-
associated markers (OCT4, cMYC, SOX2, and KLK4) ver-
sus DFs [34]. These proteins are transcription factors that
are essential for maintaining the self-renewal capacity or
pluripotency [35]. The iPS cells offer an advantage over
traditional MSCs because they display an unlimited growth
capacity that can serve as an inexhaustible source of stem cells
[36]. A similar comparable report analyzed that dental tissue
derived mesenchymal-like stem cells can be reprogrammed
into iPSCs more efficiently, when compared to other mature
somatic cells from human body such as adultMSCs and adult
dermal fibroblasts [37].
The accessibility of dental tissue, including MSCs, might
still be limited because these cells can only be isolated
under specific circumstances, such as during the extraction
of teeth. However, the gingiva is one of the most convenient
tissues to collect by biopsy, with less scar formation and less
postsurgical donor discomfort. In addition, gingival tissues
are routinely resected during dental procedures in children,
such as surgical extraction of impacted teeth and surgical
opening for teeth with delayed eruption, and these tissues are
generally treated as biomedical waste. In the laboratory, it is
also feasible to isolate stem cells from gingival tissue based
on their highly proliferative nature. Thus, the gingiva can be
an important alternative source of stem cells in regenerative
dentistry. If stem cells isolated from gingival tissue can
be utilized similar to the storage of umbilical cord blood,
the dynamic features of these cells reveal much potential
for their use. Although this study is limited to monitoring
expression patterns without a clinical link, comparative gene
expression analysis of different tissues might provide genetic
information concerning functions, such as tissue repair and
tooth development. Further investigations are needed to
evaluate the neurogenesis capacity, mineralization potential,
and cell proliferation capacity of stem cells from gingiva and
dental follicles based on of this study.
5. Conclusion
For the first time, this study profiles differential gene
expression between the gingiva and DFs. cDNA microarray
was performed to characterize and compare the molecular
fingerprints of stemness. The DFs have been considered a
multipotent tissue based on their ability to generate cemen-
tum, bone, and PDL. While the gingiva was not noticed
for pluripotent stemness before, this study demonstrated
transcription factors of iPS cells were expressed at higher
levels in the gingiva and most dental-derived stem cell
markers were strongly upregulated in the DFs. Given the
minimal postsurgical discomfort and simple accessibility of
gingival tissue, the gingiva is a good candidate stem cell
source in regenerative dentistry.
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